Breaking News
February 22, 2019 - Researchers create new map of the brain’s own immune system
February 22, 2019 - ICHE’s reviews on surgical infections, unnecessary urine tests, and nurses’ role in antibiotic stewardship
February 22, 2019 - UK Research and Innovation invests £200 million to create new generation of AI leaders
February 22, 2019 - Takeda collaboration to boost fight against Alzheimer’s and other neurodegenerative diseases
February 22, 2019 - Heavy drinking may change DNA, leading to increased craving for alcohol
February 22, 2019 - U.S. opioid deaths jump fourfold in 20 years; epidemic shifts to Eastern states | News Center
February 22, 2019 - 5 Questions with William Turner on Diversity in Medicine
February 22, 2019 - HHS Finalizes Rule Seeking To Expel Planned Parenthood From Family Planning Program
February 22, 2019 - Researchers uncover biochemical pathway that may help identify drugs to treat Alzheimer’s
February 22, 2019 - Biologist uses new grant to find ways to eliminate schistosomiasis
February 22, 2019 - Bag-mask ventilation to help patients breathe during intubation prevents complications
February 22, 2019 - AbbVie Announces New Drug Application Accepted for Priority Review by FDA for Upadacitinib for Treatment of Moderate to Severe Rheumatoid Arthritis
February 22, 2019 - Nature versus nurture and addiction
February 22, 2019 - New website connects researchers with data experts, resources | News Center
February 22, 2019 - Today’s Concerns About Drug Prices Echo The Past
February 22, 2019 - CT and Doppler equipment have low accuracy in detecting cerebral vasospasm and ischemia
February 22, 2019 - Study finds out similarity in function between healthy retina cell and tumor cell
February 22, 2019 - CWRU awarded NIH grant to identify effective treatments for intimate partner violence
February 22, 2019 - Oncotype DX Not Cost-Effective for Low-Risk Breast Cancer
February 22, 2019 - Scientists discover new type of immune cells that are essential for forming heart valves
February 22, 2019 - Talk About Déjà Vu: Senators Set To Re-Enact Drug Price Hearing Of 60 Years Ago
February 22, 2019 - Genetic defect linked to pediatric liver disease identified
February 22, 2019 - New cellular atlas could provide a deeper insight into blinding diseases
February 22, 2019 - Growing number of cancer survivors, fewer providers point to challenge in meeting care needs
February 22, 2019 - Innovative compound offers a new therapeutic approach to treat multiple sclerosis
February 22, 2019 - $1.5 million grant to develop opioid treatment program for jail detainees
February 22, 2019 - FDA’s new proposed rule would update regulatory requirements for sunscreen products in the U.S
February 22, 2019 - Most Hip, Knee Replacements Last Decades, Study Finds
February 22, 2019 - Wellness problems prevalent among ob-gyn residents
February 22, 2019 - In the Spotlight: “The world is your oyster in geriatrics”
February 22, 2019 - Successful testing of multi-organ “human-on-a-chip” could replace animals as test subjects
February 22, 2019 - Analysis of cervical precancer shows decline in two strains of HPV
February 22, 2019 - Sugary stent eases suturing of blood vessels
February 22, 2019 - From surgery to psychiatry: A medical student reevaluates his motivations
February 22, 2019 - Is New App From Feds Your Answer To Navigating Medicare Coverage? Yes And No
February 22, 2019 - New pacemakers powered by heartbeats could reduce need for surgery
February 22, 2019 - The United States records highest drug overdose death rates
February 22, 2019 - Phase 1 data reinforce safety profile of new drug for treating Duchenne muscular dystrophy
February 22, 2019 - Vitamin D supplementation less effective in the presence of obesity, shows study
February 22, 2019 - Novostia raises CHF 6.5 million to advance its aortic, mitral heart valve to clinical trials
February 22, 2019 - CPRIT awards nearly $20 million to The University of Texas MD Anderson Cancer Center
February 22, 2019 - Sarepta Announces FDA Acceptance of Golodirsen (SRP-4053) New Drug Application for Patients with Duchenne Muscular Dystrophy Amenable to Skipping Exon 53
February 22, 2019 - An institutional effort to reduce the amount of opioids prescribed following lumbar surgery
February 22, 2019 - Family-history-based models perform better than non-family-history based models
February 22, 2019 - Failure to take statins leads to higher mortality rates | News Center
February 22, 2019 - New study explains why some patients report phantom sensations after limb amputation
February 22, 2019 - First motor-controlled heart valves implanted by Mainz University Medical Center
February 22, 2019 - Novel preclinical model mimics persistent interneuron loss seen in preterm infants
February 22, 2019 - Global health burden of glaucoma has increased, study reveals
February 22, 2019 - A holistic approach key to minimize treatment complexity in patients with interstitial lung disease
February 22, 2019 - 1 in 10 middle-aged Chinese adults are at high risk for heart disease, finds study
February 22, 2019 - More than half a million breast cancer patient’s lives saved by improvements in treatment
February 22, 2019 - Study finds no evidence that tougher policies prevent teenage cannabis use
February 22, 2019 - New blood test detects genetic disorders in fetuses
February 22, 2019 - Lower Self-Perception Observed in Children With Amblyopia
February 22, 2019 - Up to 15 percent of children have sleep apnea, yet 90 percent go undiagnosed
February 22, 2019 - Rare pulmonary defect prompts parents’ nationwide search for answers | News Center
February 22, 2019 - Lesbian and bisexual women at greater risk of being overweight, study finds
February 22, 2019 - UQ research may explain why vitamin D is essential for brain health
February 22, 2019 - Heart Attacks Rising Among Younger Women
February 22, 2019 - How your smartphone is affecting your relationship
February 22, 2019 - Orthopaedic surgeon receives prestigious award, $10 million grant | News Center
February 22, 2019 - New sepsis test could save thousands of lives
February 22, 2019 - Cervical cancer could be eradicated by 2100
February 21, 2019 - Sustained smoking cessation can lower risk of seropositive RA
February 21, 2019 - Thousands with chronic UTIs are not receiving the treatment they need
February 21, 2019 - Are teens getting high on social media? The surprising study seeking the pot-Instagram link
February 21, 2019 - Stanford expands biobank services | News Center
February 21, 2019 - Scientists identify link between drinking contexts and early onset intoxication among adolescents
February 21, 2019 - Strong social support may reduce cardiovascular disease risk in postmenopausal women
February 21, 2019 - Rapid expansion of interventions could prevent up to 13 million cases of cervical cancer within 50 years
February 21, 2019 - Motif Bio Receives Complete Response Letter From The FDA
February 21, 2019 - Researchers map previously unknown disease in children
February 21, 2019 - A skeptical look at popular diets: Going gluten-free
February 21, 2019 - Podcast: KHN’s ‘What The Health?’ How Safe Are Your Supplements?
February 21, 2019 - Factors associated with increased risk of developing surgical site infections
February 21, 2019 - Anticipatory signals in eye movements can help measure attentive capacity, learning with greater precision
February 21, 2019 - Study explores daily exposure to indoor air pollutants
February 21, 2019 - Evening exercise does not negatively affect sleep, may also reduce hunger
February 21, 2019 - Artificial intelligence technique can be used to identify alcohol misuse in trauma setting
Philips introduces Ingenia Ambition X 1.5T MR with fully-sealed BlueSeal magnet for helium-free operations

Philips introduces Ingenia Ambition X 1.5T MR with fully-sealed BlueSeal magnet for helium-free operations

image_pdfDownload PDFimage_print

Ingenia Ambition X combines fully-sealed BlueSeal magnet technology and workflow innovations for step-change in productivity

Royal Philips, a global leader in health technology, today launched the Ingenia Ambition X 1.5T MR. Incorporating Philips’ breakthrough BlueSeal fully-sealed magnet, the Ingenia Ambition X is the world’s first MR system to enable helium-free operations, reducing the chance of potentially lengthy and costly disruptions, and virtually eliminating dependency on a commodity with an unpredictable supply. The first commercial installation of the Ingenia Ambition X was recently completed at Spital Uster Hospital, a major provider of extended primary healthcare in the canton of Zurich, Switzerland. The Ingenia Ambition X is CE marked and has received 510(k) clearance from the U.S. Food and Drug Administration (FDA).

“We are very proud to be the first hospital in the world to offer this new cutting edge, resource-friendly MRI technology to our patients,” said Dr Andreas Steinauer, Chief Radiologist at Spital Uster Hospital, Switzerland. “With the new Philips Ingenia Ambition X our patients can have the best of two worlds: leading MRI technology with a smaller footprint. This new leaner platform will allow more sites to deliver advanced MRI technology to their patients, helping to improve patient care.”

This announcement completes the renewal of the Ingenia MRI portfolio, which comprises fully-digital MRI systems, healthcare informatics and a range of maintenance and life cycle services for integrated solutions that support customers’ needs for first-time-right imaging, enhanced diagnostic capabilities and improved productivity.

1.5T MR imaging is core to the day-to-day operations of radiology departments in the UK and around the world, supporting clinicians in the diagnosis of a wide range of patient conditions. As demand for care increases and budgets become more constrained, improvements in productivity of this diagnostic mainstay can have a significant impact. The Ingenia Ambition X can substantially improve overall efficiency, combining its revolutionary BlueSeal magnet with innovations that can reduce downtime, enable single operator workflow and speed up exam times by up to 50 %.

“MRI provides exceptional diagnostic and therapy guidance capabilities, but it also places substantial operational demands on the hospital or imaging center due to requirements for installation, footprint and services,” said Ben Huard, Business Marketing Manager, MR at Philips UK. “With our breakthrough fully-sealed BlueSeal technology we’re dramatically cutting the amount of liquid helium needed to cool the magnet to less than half a percent of the current norm. The result is numerous customer benefits from a smaller, lighter and more flexible installation footprint, and a more efficient return to normal operations when required.”

A wealth of innovations delivers step-change in MR productivity

The Ingenia Ambition X includes a range of innovative features that combine to deliver a step-change in productivity. With Philips’ EasySwitch services, the BlueSeal’s magnetic field can be easily turned off if an item becomes stuck in the bore. Once the problem is resolved, an in-house or Philips technician can initiate an automated ramp-up to bring the magnet back to field, minimizing operational downtime. A conventional MR typically requires two staff to manage daily operations. The Ingenia Ambition X combines guided patient setup and Adaptive Intelligence-driven SmartExam analytics for automatic planning, scanning and processing. This frees up time to enable a single operator to manage the full scan from the patient’s side with just a single touch of a button.

Philips Compressed SENSE is an advanced acceleration application that reduces exam times by up to 50%. In addition, Philips VitalEye is a unique approach to detecting patient physiology and breathing movement. VitalEye technology and algorithms intelligently extract signs of breathing – allowing routine exam set-up time to occur in less than a minute, even for less experienced operators. Together, these innovations help to standardize and speed up workflow, allowing clinicians to focus on the patient.

The Ingenia Ambition X is part of the all-new Ingenia digital MR portfolio and complements the recently introduced Ingenia Elition and Ingenia Prodiva MR solutions. For more information about Philips’ MR portfolio and to see how Philips’ MR Innovations are improving diagnostic speed, comfort and confidence visit the next MR wave webpage.

Tagged with:

About author

Related Articles